Source: Imaging Tech; Editor: Liu Xinyi
Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.
On January 8, 2024, GE Healthcare (Nasdaq: GEHC) announced that it has entered the agreement phase for the acquisition of MIM Software, a medical imaging software company.
The financial details of this transaction have not been publicly disclosed, but GE Healthcare stated that the reason for acquiring the company is toImplement the company's "Precision Care" strategy, hoping to leverage the company's products in imaging analysis and digital workflow capabilities across various care areas, making GE Healthcare's solutions exceptional.MIM Software, Inc. is an American medical imaging software company founded in 2003, headquartered in Cleveland, Ohio, with offices in China and Belgium.The company aims toRadiation Oncology, Nuclear Medicine, Radiology, Interventional Radiology, Molecular, Neurological and Cardiac ImagingProviding innovative software solutions. The company has launched software such as MIM Maestro®, Contour ProtégéAI+™, and MIM Encore® to date.
MIM Maestro® User InterfaceThe company's innovative imaging solutions portfolio offers several features, including:- Integrating diagnostic images of multiple modalities into the treatment plan;
- Provides multi-step automation, which helps reduce repetitive tasks and manual effort;
- Apply quantitative and advanced processing in the field of diagnostic imaging and nuclear medicine to confirm treatment efficacy;
- Provide a platform that supports therapeutic diagnostic imaging and radiation dosimetry, assisting doctors in developing better treatment plans.
GE Healthcare Plans to Integrate MIM Software's Solutions into Its Advanced Visualization Products to Support AI-Based Image Segmentation, Contouring, and Radiation Dose Analysis Services. This Integration Aims to Help Medical Institutions Provide Better Medical Imaging for Patients While Driving Innovation in Radiology, Molecular Imaging, and Radiation Oncology.As novel therapies become increasingly accessible, healthcare providers are in greater need of advanced imaging, workflow, and digital solutions to deliver critical information that helps doctors create more effective treatment plans faster. This working agreement between GE Healthcare and MIM Software highlights their commitment to advancing into the future.In the future, GE Healthcare's focus on precision care will include the treatment and diagnosis of advanced prostate cancer, streamlining of radiation oncology workflows, β-amyloid imaging for Alzheimer’s disease, and applications of myocardial perfusion in coronary artery disease.GE Healthcare President and CEO Peter Arduini said, "We hope to bring together these two complementary organizations and innovative product portfolios to strengthen our capabilities as a leading provider of integrated imaging systems, analytics, and advanced digital workflows."Andrew Nelson, CEO of MIM Software, stated: "For the past two decades, we have been committed to developing innovative, vendor-neutral products and providing high-quality services. After joining GE Healthcare, we look forward to creating newer and more integrated digital solutions."On January 4, 2023, GE Healthcare announced that the previously announced spin-off from GE Group (NASDAQ: GE) has been completed. GE Healthcare will begin trading on the Nasdaq Stock Exchange as an independent company with the stock code "GEHC," effective at market open. GE Healthcare became the first company in Wisconsin, USA, to remotely ring the Nasdaq opening bell for its IPO.GE Healthcare has approximately 51,000 employees worldwide, serving over 1 billion patients annually across more than 160 countries. GE Healthcare operates through four business segments ——Medical Imaging、Ultrasound、PCS Patient Care SolutionsAndDrug Diagnosis。On October 31, 2023, GE Healthcare announced its financial results for the third quarter ended September 30, 2023: reported revenue reached $4.8 billion, a year-over-year increase of 5%, with organic revenue growth of 6% year-over-year; net profit was $375 million, compared to $487 million in the same period last year.
International Medical Imaging Enterprises:Chinese Medical Imaging Companies:
Editor-in-Chief | Zhao Qing Reviewed by | Yi He
